All lobbying filings

Danaher Corporation

Danaher Corporation filed a Q2 report for Danaher Corporation on July 20, 2026.

Lobbying for Danaher Corporation · health care products developer and manufacturer

As filed: DANAHER CORPORATION for DANAHER CORPORATION.

All filings by Danaher Corporation · Everything Danaher Corporation has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Expenses

$200,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Issues related to biotechnology, cell and gene therapy

Tariff (miscellaneous tariff bills)

General issues related to tariffs

Environment/Superfund

Issues related to decarbonization

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.